Atea Pharmaceuticals Inc (AVIR) — Cash Flow Reinvestment Rate
Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting $4.00K (capex $4.00K ) from operating cash flow of $22.60 Million. Check Atea Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Atea Pharmaceuticals Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Atea Pharmaceuticals Inc across 1 annual periods. Explore AVIR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Atea Pharmaceuticals Inc (2020–2020)
Year-by-year capital reinvestment analysis for Atea Pharmaceuticals Inc. For live market cap and broader valuation context, see Atea Pharmaceuticals Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | $52.00K | $296.73 Million | $26.00K | — |